Mereo BioPharma Group (STU:MAH0) Effective Interest Rate on Debt % : 19.44% (As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is Mereo BioPharma Group Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Mereo BioPharma Group's annualized positive value of Interest Expense for the quarter that ended in Mar. 2025 was €0.66 Mil. Mereo BioPharma Group's average total debt for the quarter that ended in Mar. 2025 was €3.42 Mil. Therefore, Mereo BioPharma Group's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 was 19.44%.

Mereo BioPharma Group Effective Interest Rate on Debt % Historical Data

The historical data trend for Mereo BioPharma Group's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mereo BioPharma Group Effective Interest Rate on Debt % Chart

Mereo BioPharma Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Effective Interest Rate on Debt %

Get a 7-Day Free Trial

24.51

23.83

22.83

26.46

22.56

Mereo BioPharma Group Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Effective Interest Rate on Debt %	Get a 7-Day Free Trial															20.73	21.81	21.66	23.55	19.44

Competitive Comparison of Mereo BioPharma Group's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Mereo BioPharma Group's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mereo BioPharma Group's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mereo BioPharma Group's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Mereo BioPharma Group's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Mereo BioPharma Group Effective Interest Rate on Debt % Calculation

Mereo BioPharma Group's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2023 )	+	Total Debt (A: Dec. 2024 ))	/ count )
=	-1 * -1.308	/	( (5.458	+	6.14)	/ 2 )
=	-1 * -1.308	/	5.799
=	22.56 %

where

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	4.86	+	0.598
=	5.458

	Total Debt (A: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.179	+	5.961
=	6.14

Mereo BioPharma Group's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2025 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Dec. 2024 )	+	Total Debt (Q: Mar. 2025 ))	/ count )
=	-1 * -0.664	/	( (6.14	+	0.691)	/ 2 )
=	-1 * -0.664	/	3.4155
=	19.44 %

where

	Total Debt (Q: Dec. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0.179	+	5.961
=	6.14

	Total Debt (Q: Mar. 2025 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0.691
=	0.691

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2025) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Mereo BioPharma Group (STU:MAH0) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Mereo BioPharma Group Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Mereo BioPharma Group's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mereo BioPharma Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mereo BioPharma Group PLC (STU:MAH0) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

MREO:USA 0A9G:UK

Address

One Cavendish Place, 4th Floor, London, GBR, W1G 0QF

Website

https://www.mereobiopharma.com

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group Headlines

No Headlines